Seer Biosciences, Inc. — Form D
Seer Biosciences, Inc. of BOSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2018-01-04. The offering totals $6.0M, of which $6.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2018-01-04
- Form: D
- Accession: 0001726445-18-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $6.0M
- Amount sold: $6.0M
- Investors: 11
- Date of first sale: 2017-12-20
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-302425
Issuer
- Name: Seer Biosciences, Inc.
- CIK: 0001726445
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: C/O FOLEY HOAG LLP, BOSTON, MA, 02210
- Phone: 408-307-1702
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Omid Farokhzad | Director | Boston, MA |
| Robert Langer | Director | Pittsburgh, PA |
| Terrance McGuire | Director | Cambridge, MA |
| David Singer | Director | Cherry Hill, NJ |
| Shadi Aryanpour | Executive Officer | Boston, MA |
| Philip Ma | Executive Officer | Boston, MA |
More